We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+10.9%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$27.8B
AUM Growth
+$3.36B
(+14%)
Cap. Flow
+$723M
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
55.63%
Holding
2,156
New
217
Increased
776
Reduced
764
Closed
175
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core US Aggregate Bond ETF
AGG
|
+$157M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$117M |
| 3 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$105M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$94M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$93.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Mid-Cap ETF
VO
|
+$63.3M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$32.3M |
| 3 |
Schwab US REIT ETF
SCHH
|
+$21.3M |
| 4 |
Vanguard Energy ETF
VDE
|
+$18.8M |
| 5 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.74% |
| 2 | Technology | 4.11% |
| 3 | Healthcare | 2.19% |
| 4 | Energy | 2.03% |
| 5 | Consumer Discretionary | 1.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BZUN
1351
Baozun
BZUN
$144M
| $286K | ﹤0.01% |
+6,878
| New | +$241K |
|
1352
Ormat Technologies
ORA
$6.11B
| $286K | ﹤0.01% |
5,189
+27
| +0.5% | +$1.5K |
|
1353
Sun Life Financial
SLF
$45.6B
| $286K | ﹤0.01% |
7,457
-4,426
| -37% | -$162K |
|
|
CRC
1354
DELISTED
California Resources Corporation
CRC
| $286K | ﹤0.01% |
11,105
-642
| -5% | -$13.9K |
|
1355
Cimpress
CMPR
$2.37B
| $285K | ﹤0.01% |
3,551
-13
| -0.4% | -$1.19K |
|
1356
BWX Technologies
BWXT
$16B
| $284K | ﹤0.01% |
+5,737
| New | +$271K |
|
|
EFT
1357
Eaton Vance Floating-Rate Income Trust
EFT
$283M
| $284K | ﹤0.01% |
21,505
| – | – |
|
1358
Verastem
VSTM
$532M
| $284K | ﹤0.01% |
8,008
+339
| +4% | +$13.4K |
|
|
DHC
1359
Diversified Healthcare Trust
DHC
$2.26B
| $283K | ﹤0.01% |
24,038
-1,617
| -6% | -$20.7K |
|
1360
Novavax
NVAX
$1.23B
| $283K | ﹤0.01% |
25,666
+15,860
| +162% | +$501K |
|
1361
HealthEquity
HQY
$7.91B
| $282K | ﹤0.01% |
3,817
-203
| -5% | -$14.3K |
|
1362
Rockwell Medical
RMTI
$26.2M
| $282K | ﹤0.01% |
451
+26
| +6% | +$11.9K |
|
1363
Super League Enterprise
SLE
$4.28M
| $282K | ﹤0.01% |
+4
| New | +$307K |
|
|
TWO
1364
Two Harbors Investment
TWO
$1.27B
| $282K | ﹤0.01% |
5,218
-984
| -16% | -$55.1K |
|
1365
Liberty All-Star Equity Fund
USA
$1.75B
| $281K | ﹤0.01% |
46,070
-8,333
| -15% | -$49.3K |
|
1366
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.82B
| $280K | ﹤0.01% |
5,320
-299
| -5% | -$15.1K |
|
|
SRCL
1367
DELISTED
Stericycle Inc
SRCL
| $280K | ﹤0.01% |
5,150
-2,180
| -30% | -$98.7K |
|
1368
Celanese
CE
$5.09B
| $279K | ﹤0.01% |
2,831
-432
| -13% | -$42.5K |
|
1369
Lennar Class A
LEN
$20.4B
| $278K | ﹤0.01% |
5,841
-100
| -2% | -$4.53K |
|
1370
Universal Health Services
UHS
$9.43B
| $278K | ﹤0.01% |
+2,078
| New | +$274K |
|
|
LMNX
1371
DELISTED
Luminex Corp
LMNX
| $278K | ﹤0.01% |
12,072
-107
| -0.9% | -$2.69K |
|
1372
Fidelity MSCI Health Care Index ETF
FHLC
$3.27B
| $276K | ﹤0.01% |
+6,208
| New | +$271K |
|
1373
Old National Bancorp
ONB
$10.1B
| $276K | ﹤0.01% |
16,810
-28
| -0.2% | -$468 |
|
|
SGMO
1374
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $275K | ﹤0.01% |
28,839
+5,555
| +24% | +$56.7K |
|
|
GSS
1375
DELISTED
Golden Star Resources Ltd.
GSS
| $275K | ﹤0.01% |
69,279
| – | – |
|
Similar funds
Creative Planning's Q1 2019 Portfolio in Review
As of Q1 2019, Creative Planning held 2,156 positions worth $27.8B, up 14% from $24.4B the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Creative Planning's Q1 2019 filing shows 217 new, 776 increased, 764 reduced and 175 closed positions. Its largest new stake was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M. The largest sale was Vanguard Mid-Cap ETF, an estimated $63.3M.
By sector, the portfolio is most concentrated in Financials at 4.7% of assets, down from 5.2% a quarter earlier, followed by Technology and Healthcare.
- Creative Planning's largest Q1 2019 buy was Intercept Pharmaceuticals, Inc.: 33,175 shares worth $3.71M.
- Creative Planning added most to iShares Core US Aggregate Bond ETF in Q1 2019, an estimated $157M increase.
- Creative Planning's biggest Q1 2019 reduction was Vanguard Mid-Cap ETF, cutting an estimated $63.3M.
- Creative Planning fully exited Kforce in Q1 2019, selling an estimated $3.23M.
- Creative Planning's ten largest holdings make up 56% of its $27.8B portfolio in Q1 2019.
- Creative Planning opened 217 new positions and closed 175 in Q1 2019.
- Creative Planning's portfolio value rose 14% quarter-over-quarter to $27.8B.
Based on Creative Planning's 13F filing for Q1 2019, filed 24 Apr 2019.